To investigate the role of TRAF3IP2-AS1 in NONO-TFE3 tRCC progression, we first evaluated TRAF3IP2-AS1 expression levels in various RCC cell lines and normal cell. The gene discussed is TFE3; the disease is renal cell carcinoma.